GLP-1 RAs May Up Optic Neuropathy Risk in Seniors With Diabetes

Use of GLP-1s, especially semaglutide and liraglutide, may increase risk for nonarteritic anterior ischemic optic neuropathy in older patients with type 2 diabetes, a study of Medicare enrollees shows.
Medscape Medical News